HealthcareServices

BNP And NTproBNP Market Forecast 2026: Where the Industry Is Headed

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the bnp and ntprobnp market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the BNP And NTproBNP Market in 2026, and what figure is it projected to hit by 2030?

The bnp and ntprobnp market has shown significant growth in recent years. It is anticipated to increase from $2.26 billion in 2025 to $2.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.2%. This historical expansion can be attributed to several factors, including the rising prevalence of cardiovascular diseases, increased clinical adoption of bnp testing, the expansion of hospital diagnostic infrastructure, growing awareness of early heart failure detection, and the availability of laboratory immunoassay technologies.

The bnp and ntprobnp market size is anticipated to undergo considerable growth over the next few years. It is forecast to reach $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to several factors, including the escalating demand for rapid cardiac diagnostics, the broadening adoption of point-of-care testing, an increasing elderly population base, the rising integration of AI-assisted diagnostic interpretation, and a greater emphasis on preventive cardiology care. Prominent trends expected in the forecast period encompass the increasing uptake of high-sensitivity cardiac biomarker assays, a rise in the deployment of point-of-care bnp testing devices, the growing integration of automated laboratory diagnostics, the expansion of early heart failure screening programs, and an enhanced focus on diagnostic testing with rapid turnaround times.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10673&type=smp

Which Drivers Are Affecting Market Participation In The BNP And NTproBNP Market?

The increasing number of older adults is anticipated to fuel expansion in the BNP and NT-proBNP market going forward. This demographic refers to individuals aged 65 and above. BNP and NT-proBNP are crucial biomarkers for seniors, facilitating heart failure diagnosis and management through insights into heart function and guiding suitable therapies for the elderly. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 individuals will be 60 or older by 2030 and is expected to reach 2.1 billion elderly people by 2050. Consequently, the expanding geriatric demographic is a key factor propelling the BNP and NT-proBNP market’s development.

What Segment Classifications Make Up The BNP And NTproBNP Market?

The bnp and ntprobnp market covered in this report is segmented –

1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications

Subsegments:

1) By BNP (Brain Natriuretic Peptide): BNP Testing Kits, Point-Of-Care BNP Testing Devices, Laboratory BNP Assays

2) By NT-ProBNP (N-Terminal Pro–B-Type Natriuretic Peptide): NT-ProBNP Testing Kits, Point-Of-Care NT-proBNP Testing Devices, Laboratory NT-ProBNP Assays

Which Trends Are Influencing The Performance And Direction Of The BNP And NTproBNP Market?

Leading companies within the BNP and NTproBNP market are intensifying their efforts to launch rapid screening bioassays, aiming to secure a competitive advantage. These rapid screening bioassays are defined as biological tests designed to efficiently evaluate a substance’s presence, concentration, or activity by observing its impact on living cells or organisms, thereby facilitating prompt and dependable identification or classification of particular characteristics or states. For instance, in October 2023, Mindray Medical International Limited, a medical device firm based in China, introduced two novel assays intended for the diagnosis and management of cardiovascular diseases (CVDs). These specific assays are named high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Incorporating these additions into its varied collection of cardiac biomarkers, Mindray has improved its capabilities in screening, risk stratification, swift diagnosis, and therapeutic monitoring for CVDs. Mindray collaborated with HyTest, a leader in cardiac biomarkers, to incorporate HyTest’s research and antibodies into its own immunoassay platforms.

Which Key Players Are Driving Competition In The BNP And NTproBNP Market?

Major companies operating in the bnp and ntprobnp market are Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Which Region Is Projected To Lead The BNP And NTproBNP Market During The Forecast Period?

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2025.North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized BNP And NTproBNP Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10673&type=smp

Browse Through More Reports Similar to the Global BNP And NTproBNP Market 2026, By The Business Research Company

Consumer And Smb Nas Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-and-smb-nas-global-market-report

B2B2C Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/b2b2c-insurance-global-market-report

B2B Telecommunication Market Report 2026

https://www.thebusinessresearchcompany.com/report/b2b-telecommunication-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795